We are live on ! Find out more
William Blair & Company

William Blair & Company Portfolio holdings

AUM $38.4B
1-Year Est. Return 25.71%
This Fund
S&P 500
This Quarter Est. Return
+6.81%
1 Year Est. Return
+25.71%
3 Year Est. Return
+88.7%
5 Year Est. Return
+104.53%
10 Year Est. Return
+665.86%
AUM
$17.5B
AUM Growth
+$1.09B
Cap. Flow
+$196M
Cap. Flow %
1.12%
Top 10 Hldgs %
22.04%
Holding
1,814
New
115
Increased
670
Reduced
633
Closed
80

Top Buys

Rank Stock Value
1
FISV
Fiserv Inc
FISV
+$41.9M
2
DLB icon
Dolby
DLB
+$23M
3
TDOC icon
Teladoc Health
TDOC
+$20.9M
4
CPRT icon
Copart
CPRT
+$20.8M
5
DXCM icon
DexCom
DXCM
+$16M

Sector Composition

Rank Sector Weight
1 Technology 22.57%
2 Healthcare 17.89%
3 Financials 12.54%
4 Consumer Discretionary 10.12%
5 Industrials 9.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BSJL
1551
DELISTED
Invesco BulletShares 2021 High Yield Corporate Bond ETF
BSJL
$25K ﹤0.01%
1,000
EUFN icon
1552
iShares MSCI Europe Financials ETF
EUFN
$4.29B
$24K ﹤0.01%
1,300
SCHR
1553
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.3B
$24K ﹤0.01%
874
SPYG icon
1554
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$55.1B
$24K ﹤0.01%
610
+447
+274% +$17K
XHS icon
1555
State Street SPDR S&P Health Care Services ETF
XHS
$207M
$24K ﹤0.01%
354
-210
-37% -$13.5K
EQAL icon
1556
Invesco Russell 1000 Equal Weight ETF
EQAL
$844M
$23K ﹤0.01%
+697
New +$22.5K
IYM icon
1557
iShares US Basic Materials ETF
IYM
$1.02B
$23K ﹤0.01%
240
+19
+9% +$1.75K
XPH icon
1558
State Street SPDR S&P Pharmaceuticals ETF
XPH
$510M
$23K ﹤0.01%
532
SLY
1559
DELISTED
SPDR S&P 600 Small Cap ETF (based on S&P SmallCap 600 Index--symbol SML)
SLY
$23K ﹤0.01%
340
+20
+6% +$1.34K
EEMS icon
1560
iShares MSCI Emerging Markets Small-Cap ETF
EEMS
$379M
$22K ﹤0.01%
500
EZA icon
1561
iShares MSCI South Africa ETF
EZA
$567M
$21K ﹤0.01%
296
IHE icon
1562
iShares US Pharmaceuticals ETF
IHE
$1.65B
$21K ﹤0.01%
420
ISCV icon
1563
iShares Morningstar Small-Cap Value ETF
ISCV
$706M
$21K ﹤0.01%
456
+6
+1% +$277
LIT icon
1564
Global X Lithium & Battery Tech ETF
LIT
$1.61B
$21K ﹤0.01%
808
PBE icon
1565
Invesco Biotechnology & Genome ETF
PBE
$358M
$21K ﹤0.01%
400
SMLV icon
1566
State Street SPDR US Small Cap Low Volatility Index ETF
SMLV
$261M
$21K ﹤0.01%
224
IBDM
1567
DELISTED
iShares iBonds Dec 2021 Term Corporate ETF
IBDM
$21K ﹤0.01%
825
INOD icon
1568
Innodata
INOD
$2.01B
$20K ﹤0.01%
22,000
NFRA icon
1569
FlexShares STOXX Global Broad Infrastructure Index Fund
NFRA
$3.03B
$20K ﹤0.01%
400
-100
-20% -$5.01K
OIH icon
1570
VanEck Oil Services ETF
OIH
$1.96B
$20K ﹤0.01%
67
-40
-37% -$12.5K
IBDL
1571
DELISTED
iShares iBonds Dec 2020 Term Corporate ETF
IBDL
$20K ﹤0.01%
800
ARC
1572
DELISTED
ARC Document Solutions, Inc.
ARC
$20K ﹤0.01%
10,000
ARKK icon
1573
ARK Innovation ETF
ARKK
$6.44B
$19K ﹤0.01%
390
+100
+34% +$4.55K
FTSL icon
1574
First Trust Senior Loan Fund ETF
FTSL
$2.33B
$19K ﹤0.01%
400
IXP icon
1575
iShares Global Comm Services ETF
IXP
$561M
$19K ﹤0.01%
328
+4
+1% +$230

Similar funds

William Blair & Company's Q2 2019 Portfolio in Review

As of Q2 2019, William Blair & Company held 1,814 positions worth $17.5B, up 6.6% from $16.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

William Blair & Company's Q2 2019 filing shows 115 new, 670 increased, 633 reduced and 80 closed positions. Its largest new stake was Q2 Holdings: 213,468 shares worth $16.3M. The largest sale was Red Hat Inc, an estimated $144M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • William Blair & Company's largest Q2 2019 buy was Q2 Holdings: 213,468 shares worth $16.3M.
  • William Blair & Company added most to Fiserv Inc in Q2 2019, an estimated $41.9M increase.
  • William Blair & Company's biggest Q2 2019 reduction was Gilead Sciences, cutting an estimated $16.4M.
  • William Blair & Company fully exited Red Hat Inc in Q2 2019, selling an estimated $144M.
  • William Blair & Company's ten largest holdings make up 22% of its $17.5B portfolio in Q2 2019.
  • William Blair & Company opened 115 new positions and closed 80 in Q2 2019.
  • William Blair & Company's portfolio value rose 6.6% quarter-over-quarter to $17.5B.

Based on William Blair & Company's 13F filing for Q2 2019, filed 13 Aug 2019.